ICRP Publication 23, Report of the ICRP Task Group on Reference Man. Pergamon Press, Oxford, 1975.
2.
BeasleyT. M.PalmerH. E.NelpW. B. (1966). Deposition and Excretion of Technetium in Humans. Health Phys., 12, 1425–1435.
3.
HaysM. T. (1973). 99mTc-Pertechnetate transport in man: absorption after subcutaneous and oral administration: secretion into saliva and gastric juice. J. Nucl. Med. 14, 331–335.
4.
HamiltonJ. G.Medical and Health Physics Division, Quarterly Report. University of California, UCRL-98 (1948) p. 8.
5.
SullivanM. F.GrahamT. M.CataldoD. A.SchreckhiseR. G.Absorption and retention of inorganic and originally incorporated technetium-95 by rats and guinea pigs. In: Pacific Northwest Laboratory Annual Report for 1977, Part 1 Biomedical Sciences, Feb. 1978, PNL-2500PT1
6.
Van KirkO.ChafetzN.CookeS.TaylorA.LarsonS. M. (1978). Imaging of the bowel with technetium—an aid in gallium studies. J. Nucl. Med. 19, 69–70.
7.
ICRP Task Group on Lung Dynamics (1966). Deposition and retention models for internal dosimetry of the human respiratory tract. Health Phys. 12, 173–207.
8.
CookeD. J.LanderH. (1971). Inhalation Pulmonary Scintiphotography using pertechnetate. Am. J. Roent. 113, 682–689.
9.
HarperP. V.LathropK. A.McCordleR. J.AndrosG.The use of technetium-99m as a clinical scanning agent for thyroid, liver and brain. In: Medical Radioisotope Scanning, Vol. 2 (IAEA, Vienna, 1964) pp. 33–45.
10.
McAfeeJ. G.FuegerC. F.SternH. S.WagnerH. N.Jr.MigataT. (1964). 99mTc pertechnetate for brain scanning. J. Nucl. Med. 5, 811–827.
11.
HaysM. T.BermanM. (1977). Pertechnetate distribution in man after intravenous infusion: a compartmental model. J. Nucl. Med. 18, 898–904.
12.
ICRP Publication 17, Protection of the patient in radionuclide investigations. Pergamon Press, Oxford, 1971.
13.
ICRP Publication 25, Handling, storage, use and disposal of unsealed radionuclides in hospitals and medical research establishments. Pergamon Press, Oxford, 1977.